
Pamlab headquarters is located in Covington, Louisiana. The company has been in the pharmaceutical industry since 1957, over 50 years. Initially, the company introduced numerous prescription cough/cold products to prescribing physicians in Louisiana.
In 1987, the company was purchased by Samuel and Judith Camp, who recognized the need for product line expansion and professional field sales force. Over the next 10 years, the Covington, Louisiana based Pan American Laboratories grew substantially and profitably, becoming a trusted name among thousands of physicians throughout the Southeast.
Pamlab is now a fully integrated pharmaceutical company, with approximately 300 employees, specializing in prescription medical foods. Pamlab products are marketed and sold nationally.
Recently, we have expanded Pamlab to include: Pan American Laboratories and Red River Pharma.
Company Benefits
We proudly offer a comprehensive and valuable benefits package designed to fit the needs of our employees and their families. Learn More...
February, 2013
Pamlab Announces Agreement for Sale of Business to Nestlé Health Science. Acquisition Adds Value to Patients and Healthcare Providers in Brain Health and Metabolic Health. Click here to read press release.
Dr. Vivian Fonseca (immediate past President of American Diabetes Association) and Dr. John Anderson (incoming President of American Diabetes Association) conducted a CME for Medscape on diabetic peripheral neuropathy and the benefits of Metanx® therapy with T2D patients.
Metanx® clinical data is published in The American Journal of Medicine entitled "Metanx in Type 2 Diabetes with Peripheral Neuropathy: A Randomized Trial." Dr. Vivian Fonseca is the primary investigator of the study.
2013 annual National Sales Meeting for all Pamlab employees and sales force was held in New Orleans, LA.
January, 2013
Deplin® is featured in current issue of Current Psychiatry which cites Dr. George Papakostas (Mass General Hospital) research on L–methylfolate. The article is written by Dr. Drew Ramsey of Columbia University and is entitled: "Vitamin Deficiencies in Mental Health."
December, 2012
L–methylfolate research by Dr. George Papakostas (Mass General Hospital) and Dr Richard Shelton (Univ S Alabama) and Dr. John Zajecka (Rush University) has been published in the American Journal of Psychiatry. The title is: "L–Methylfolate as adjunctive therapy for SSRI–resistant major depression: results of two randomized, double–blind, parallel–sequential trials."
November, 2012
Dr. Chuck Raison (AZ), Dr. Vladimir Maletic (SC) and Dr. Rakesh Jain (TX) lead a CME course on L–methylfolate at U.S. Psych Congress in San Diego.
October, 2012
Dr. Andy Cutler (FL) lead a Deplin® Product Theater at NEI Conference in San Diego.